Condition
Endometrial Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 19 Endometrial Carcinoma clinical trials that are recruiting, at sites in 8 countries (most in United States (16), China (2), France (1)). By phase: Phase 2 (4), Phase 1/2 (3), Early Phase 1 (1), Phase 1 (1). There are also 1 NIH-funded research project on Endometrial Carcinoma, with $512,292 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 19Clinical trials
- 1NIH research projects
- 8Countries
Newest Endometrial Carcinoma clinical trials
All recruiting trials (19)
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer
This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.
-
Acceptability of DNA Markers in Vaginal Fluid for Endometrial Cancer Detection
This study asks if Black women 45 and older with bleeding symptoms feel comfortable using vaginal fluid DNA tests to help detect endometrial cancer.
-
Improved MRI methods to distinguish benign from cancerous pelvic findings
This test tries new deep-learning image-processing methods on MRI scans to get clearer images faster for adults scanned for prostate screening or suspected endometriosis.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
FT836 alone or with chemotherapy and antibody drugs for advanced solid tumors.
This trial will test if FT836, given alone or with paclitaxel and/or the antibodies trastuzumab or cetuximab, is safe and tolerable for people with advanced solid tumors who have already received prior treatment.
-
Molecular and ctDNA profiling for high-risk endometrial cancer
This project will collect blood and tumor tissue to test whether tumor DNA and other genetic changes can help predict recurrence in people with high-risk endometrial cancer.
-
Automated physical activity program for cancer patients
This study is testing whether a personalized exercise program using wearable technology can help cancer patients be more active compared to regular exercise advice.
-
Combining Carboplatin, Paclitaxel, and Pembrolizumab for Advanced Endometrial Cancer
This study is testing a new combination of drugs for people with advanced endometrial cancer to see if it helps them live longer without their cancer getting worse.
-
Combining Camrelizumab and Fluzoparib for TP-53 Mutated Endometrial Cancer
This study is testing if combining two treatments, camrelizumab and fluzoparib, can help people with TP-53 mutated endometrial cancer that has come back or spread.
-
Using AI with Ultrasound to Detect Endometrial Cancer in Post-Menopausal Women
This study is testing whether an AI program can help find endometrial cancer in women over 55 who have had postmenopausal bleeding by looking at ultrasound images.
-
Combination of a HER2-targeting vaccine and immunotherapy for advanced endometrial cancer
This study is testing a new combination treatment for advanced endometrial cancer that includes a personalized vaccine made from patients' own blood, along with other medications, to see if it helps those whose cancer has progressed after other treatments.
-
FOG-001 treatment for advanced or metastatic solid tumors
This study is testing a new drug called FOG-001 to see if it can help people with advanced solid tumors, especially those with certain genetic changes, when traditional treatments aren't working.
-
Short-course radiation therapy with chemotherapy for endometrial cancer
This study is testing a one-week radiation therapy combined with chemotherapy to see if it can be safely completed by patients with newly diagnosed stage III endometrial cancer after surgery.
-
Observing cancer recurrence using a blood test
This study is testing a new blood test to see if it can help find out if cancer comes back in people who have been treated for early-stage solid tumors.
-
Tegavivint treatment for recurrent or refractory solid tumors in children
This study tests if a new intravenous medication called tegavivint can help children with tough-to-treat solid tumors, like Ewing sarcoma and desmoid tumors, by finding the right dose and seeing how well it works.
-
Combining weight loss surgery with hysterectomy for obese women with endometrial cancer
This study is testing whether combining weight loss surgery with a hysterectomy can help obese women with endometrial cancer get better results and improve their health.
-
Niraparib treatment for advanced endometrial serous carcinoma
This study is testing if the drug niraparib can help women with advanced endometrial serous carcinoma stay cancer-free longer after their previous chemotherapy.
-
Comparing proton and intensity modulated radiation therapy after surgery for cervical or endometrial cancer
This study tests whether proton radiation therapy causes fewer side effects than intensity modulated radiation therapy in patients who have had surgery for cervical or endometrial cancer.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding and Treating High-Grade Uterine Cancer by Studying PP2A
A patient-focused look at how researchers are using mouse models with PP2A changes to learn why high-grade uterine cancers grow and how to stop them.
Related topics
Quick answers
How many Endometrial Carcinoma clinical trials are recruiting right now?
19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (16 trials), China (2 trials), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 3, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.